NCT01799538 2026-03-11
Nebulized or Inhaled Albuterol for Lymphangioleiomyomatosis
National Institutes of Health Clinical Center (CC)
Phase 1/2 Recruiting
Clinical Trials
7 trialsNCT00001465 2026-02-20
Study of the Disease Process of Lymphangioleiomyomatosis
National Institutes of Health Clinical Center (CC)
Recruiting
NCT03304678 2026-02-18
Discovery of Sirolimus Sensitive Biomarkers in Blood
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT06160310 2026-01-23
Tuberous Sclerosis Complex and Lymphangioleiomyomatosis Pregnancy Registry (TSC-LAM Registry)
Children's Hospital Medical Center, Cincinnati
Recruiting
NCT05467397 2026-01-21
Feasibility of [11C]Acetate-PET in LAM and TSC
Brigham and Women's Hospital
Phase 1/2 Active not recruiting
NCT06889168 2026-01-21
LAMP-2
Columbia University
Phase 1 Recruiting
NCT07304856 2025-12-26
Role of Extracellular Vesicles as Biomarkers of Pulmonary Involvement in Patients With Lymphangioleiomyomatosis and Tuberous Sclerosis Complex
University of Milan
Recruiting